This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Meta-Analysis

. 2001:77:233-5.

doi: 10.1007/978-3-7091-6232-3_50.

Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH

N W Dorsch¹, N F Kassell, M S Sinkula

Affiliations

PMID: 11563295
DOI: 10.1007/978-3-7091-6232-3_50

Meta-Analysis

Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH

N W Dorsch et al. Acta Neurochir Suppl. 2001.

. 2001:77:233-5.

doi: 10.1007/978-3-7091-6232-3_50.

Authors

N W Dorsch¹, N F Kassell, M S Sinkula

Affiliation

¹ Department of Neurosurgery, Westmead Hospital, New South Wales, Australia.

PMID: 11563295
DOI: 10.1007/978-3-7091-6232-3_50

No abstract available

PubMed Disclaimer

Similar articles

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG, Ilodigwe D, Macdonald RL. Jang YG, et al. Neurocrit Care. 2009;10(1):141-7. doi: 10.1007/s12028-008-9147-y. Epub 2008 Sep 23. Neurocrit Care. 2009. PMID: 18810661
Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM. Lanzino G, et al. J Neurosurg. 1999 Jun;90(6):1011-7. doi: 10.3171/jns.1999.90.6.1011. J Neurosurg. 1999. PMID: 10350245 Clinical Trial.
Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G, Kassell NF. Lanzino G, et al. J Neurosurg. 1999 Jun;90(6):1018-24. doi: 10.3171/jns.1999.90.6.1018. J Neurosurg. 1999. PMID: 10350246 Clinical Trial.
SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
Macdonald RL, Jaja B, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J; SAHIT Collaboration. Macdonald RL, et al. Transl Stroke Res. 2013 Jun;4(3):286-96. doi: 10.1007/s12975-012-0242-1. Epub 2013 Jan 7. Transl Stroke Res. 2013. PMID: 24323299 Review.
Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
Hall ED. Hall ED. Eur J Anaesthesiol. 1996 May;13(3):279-89. doi: 10.1046/j.1365-2346.1996.00980.x. Eur J Anaesthesiol. 1996. PMID: 8737119 Review.

See all similar articles

Cited by

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG, Ilodigwe D, Macdonald RL. Jang YG, et al. Neurocrit Care. 2009;10(1):141-7. doi: 10.1007/s12028-008-9147-y. Epub 2008 Sep 23. Neurocrit Care. 2009. PMID: 18810661
Management of cerebral vasospasm.
Loch Macdonald R. Loch Macdonald R. Neurosurg Rev. 2006 Jul;29(3):179-93. doi: 10.1007/s10143-005-0013-5. Epub 2006 Feb 24. Neurosurg Rev. 2006. PMID: 16501930 Review.
Intensive care of aneurysmal subarachnoid hemorrhage: an international survey.
Stevens RD, Naval NS, Mirski MA, Citerio G, Andrews PJ. Stevens RD, et al. Intensive Care Med. 2009 Sep;35(9):1556-66. doi: 10.1007/s00134-009-1533-1. Epub 2009 Jun 17. Intensive Care Med. 2009. PMID: 19533089

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information